Evidence map›Paper›PMID 36371249›Full record

Observational studyCardiovascular diabetology2022

Risk factors for cardiovascular disease in patients with metabolic-associated fatty liver disease: a machine learning approach.

Karolina Drożdż, Katarzyna Nabrdalik, Hanna Kwiendacz, Mirela Hendel, Anna Olejarz, Andrzej Tomasik, Wojciech Bartman, Jakub Nalepa, Janusz Gumprecht, Gregory Y H Lip

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Cardiovascular diabetology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
12.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 90 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Machine learning used to study risk factors for chronic diseases: A scoping review.Canadian journal of public health = Revue canadienne de sante publique · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Mechanisms Behind NAFLD: a System Genetics Perspective.Current atherosclerosis reports · 2023
    Review
  19. Observational
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Karolina DrożdżDepartment of Internal Medicine, Diabetology and Nephrology, Faculty of Medical, Sciences in Zabrze, Medical University of Silesia, 3 Maja 13-15, 41-800, Zabrze, Katowice, Poland.
Katarzyna NabrdalikDepartment of Internal Medicine, Diabetology and Nephrology, Faculty of Medical, Sciences in Zabrze, Medical University of Silesia, 3 Maja 13-15, 41-800, Zabrze, Katowice, Poland. knabrdalik@sum.edu.pl.
Hanna KwiendaczDepartment of Internal Medicine, Diabetology and Nephrology, Faculty of Medical, Sciences in Zabrze, Medical University of Silesia, 3 Maja 13-15, 41-800, Zabrze, Katowice, Poland.
Mirela HendelStudents' Scientific Association By the Department of Internal Medicine, Diabetology and Nephrology in Zabrze, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland.
Anna OlejarzStudents' Scientific Association By the Department of Internal Medicine, Diabetology and Nephrology in Zabrze, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland.
Andrzej TomasikSecond Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland.
Wojciech BartmanDepartment of Neurology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland.
Jakub NalepaDepartment of Algorithmics and Software, Silesian University of Technology, Gliwice, Poland.
Janusz GumprechtDepartment of Internal Medicine, Diabetology and Nephrology, Faculty of Medical, Sciences in Zabrze, Medical University of Silesia, 3 Maja 13-15, 41-800, Zabrze, Katowice, Poland.
Gregory Y H LipLiverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, UK.
Medical University of Silesia · PLLiverpool John Moores University · GBSilesian University of Technology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNonalcoholic fatty liver disease is associated with an increased cardiovascular disease (CVD) risk, although the exact mechanism(s) are less clear. Moreover, the relationship between newly redefined metabolic-associated fatty liver disease (MAFLD) and CVD risk has been poorly investigated. Data-driven machine learning (ML) techniques may be beneficial in discovering the most important risk factors for CVD in patients with MAFLD.

methodsIn this observational study, the patients with MAFLD underwent subclinical atherosclerosis assessment and blood biochemical analysis. Patients were split into two groups based on the presence of CVD (defined as at least one of the following: coronary artery disease; myocardial infarction; coronary bypass grafting; stroke; carotid stenosis; lower extremities artery stenosis). The ML techniques were utilized to construct a model which could identify individuals with the highest risk of CVD. We exploited the multiple logistic regression classifier operating on the most discriminative patient's parameters selected by univariate feature ranking or extracted using principal component analysis (PCA). Receiver operating characteristic (ROC) curves and area under the ROC curve (AUC) were calculated for the investigated classifiers, and the optimal cut-point values were extracted from the ROC curves using the Youden index, the closest to (0, 1) criteria and the Index of Union methods.

resultsIn 191 patients with MAFLD (mean age: 58, SD: 12 years; 46% female), there were 47 (25%) patients who had the history of CVD. The most important clinical variables included hypercholesterolemia, the plaque scores, and duration of diabetes. The five, ten and fifteen most discriminative parameters extracted using univariate feature ranking and utilized to fit the ML models resulted in AUC of 0.84 (95% confidence interval [CI]: 0.77-0.90, p < 0.0001), 0.86 (95% CI 0.80-0.91, p < 0.0001) and 0.87 (95% CI 0.82-0.92, p < 0.0001), whereas the classifier fitted over 10 principal components extracted using PCA followed by the parallel analysis obtained AUC of 0.86 (95% CI 0.81-0.91, p < 0.0001). The best model operating on 5 most discriminative features correctly identified 114/144 (79.17%) low-risk and 40/47 (85.11%) high-risk patients.

conclusionA ML approach demonstrated high performance in identifying MAFLD patients with prevalent CVD based on the easy-to-obtain patient parameters.

Indexed as

Cardiovascular DiseasesLiver DiseasesNon-alcoholic Fatty Liver DiseaseFemaleHeart Disease Risk FactorsHumansMachine LearningMaleMiddle AgedRisk FactorsCardiovascular diseaseMachine learningMetabolic-associated fatty liver disease

Identifiers

PMID36371249
PMCPMC9655870
OpenAlexW4309046344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.